These caveats are particularly important since CGRP and PACAP induced premonitory symptoms to the same extent in patients who did not develop a migraine attack as those who did, which raises the prospect that patients may have been exhibiting peptide responses that were not necessarily premonitory of migraine. This evidence concerns the gene ADCYAP1 and migraine disorder.